Reports

Industry Research Reports

Global POCT Diagnostic Analyzer Market Outlook, In‑Depth Analysis & Forecast to 2031

Global POCT Diagnostic Analyzer Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published Date: 2025-11-02

Pages: 129 Pages

Report ld: 5344942

application for samples

Request Sample

Custom reports

Customized Report

  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected
  • Description selected
  • Table of Contents selected
  • Table of Figures selected
  • Related Reports selected
  • PDFPDF Downloadselected

POCT Diagnostic Analyzer Market Size(US$)

den_QYR1
cagr

CAGR 2025-2031

4.2%

marketSize

Market Size,2031

USD 288

Million

Market Snapshot

Market Size in 2025 (Value)
US$ 225 million
Market Forecast in 2031(Value)
US$ 288 million
CAGR
4.2%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global POCT Diagnostic Analyzer market is projected to grow from US$ 217 million in 2024 to US$ 288 million by 2031, at a CAGR of 4.2% (2025-2031), driven by critical product segments and diverse end‑use applications.

Point-of-care (POC) diagnostic device is an instrument that is used to acquire particular clinical information of patients in clinical as well as resource-limited settings.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Includes:

This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global POCT Diagnostic Analyzer market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.

Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.

MARKET SEGMENTATION

By Company

  • Getein Biotech
  • Guangzhou Wondfo Biotech
  • EasyDiagnosis Biomedicine
  • Roche Holding AG
  • ABBOTT
  • Siemens Healthcare
  • BD
  • Quidel
  • Danaher Corp
  • Abaxis

Consumption by Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Segment by Type

  • Urinalysis Analyzers
  • Blood Glucose Meter
  • Clinical Chemistry Analyzers
  • Blood Gas Analyzers
  • INR Test Meter
  • Cardiac Marker Analyzers
  • Electrolyte Analyzers
  • Hemoglobin Meter
  • Other

Segment by Application

  • Hospital
  • Clinic
  • Laboratory
  • Others

biaoTi CHAPTER OUTLINE

marn_i1

Chapter 1: Defines the POCT Diagnostic Analyzer study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.

marn_i1

Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts

marn_i1

Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.

marn_i1

Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks

marn_i1

Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.

marn_i1

Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.

marn_i1

Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.

marn_i1

Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.

marn_i1

Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.

marn_i1

Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles

marn_i1

Chapter 11: Profiles players in depth—details product specs, revenue, margins; top-tier players 2024 sales breakdowns by product type, by Application, by region SWOT analysis, and recent strategic developments.

marn_i1

Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.

marn_i1

Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.

marn_i1

Chapter 14: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:

Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region
Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

den_ic6
Product mix optimization based on local practices
Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

den_ic6
Competitor tactics in fragmented vs. consolidated markets
Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

den_ic6
Full Research Coverage
Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

den_ic6
19 Years Industry Expertise
19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

den_ic6
24/7 Fast Report Delivery
24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

den_ic6
Localized Strategic Analysis
Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

den_ic6
Market entry risks/opportunities by region
Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

den_ic6
den_biaoTiZhungShi

TABLE OF CONTENTS

muLu

1 Study Coverage

1.1 Introduction to POCT Diagnostic Analyzer: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global POCT Diagnostic Analyzer Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Urinalysis Analyzers

1.2.3 Blood Glucose Meter

1.2.4 Clinical Chemistry Analyzers

1.2.5 Blood Gas Analyzers

1.2.6 INR Test Meter

1.2.7 Cardiac Marker Analyzers

1.2.8 Electrolyte Analyzers

1.2.9 Hemoglobin Meter

1.2.10 Other

1.3 Market Segmentation by Application

1.3.1 Global POCT Diagnostic Analyzer Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Laboratory

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

muLu

2 Executive Summary

2.1 Global POCT Diagnostic Analyzer Revenue Estimates and Forecasts 2020-2031

2.2 Global POCT Diagnostic Analyzer Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020-2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends

muLu

3 Competition by Players

3.1 Global POCT Diagnostic Analyzer Player Revenue Rankings and Profitability

3.1.1 Global Revenue (Value) by Players (2020-2025)

3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)

3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.1.4 Gross Margin by Top Player (2020 VS 2024)

3.2 Global POCT Diagnostic Analyzer Companies Headquarters and Service Footprint

3.3 Main Product Type Market Size by Players

3.3.1 Urinalysis Analyzers Market Size by Players

3.3.2 Blood Glucose Meter Market Size by Players

3.3.3 Clinical Chemistry Analyzers Market Size by Players

3.3.4 Blood Gas Analyzers Market Size by Players

3.3.5 INR Test Meter Market Size by Players

3.3.6 Cardiac Marker Analyzers Market Size by Players

3.3.7 Electrolyte Analyzers Market Size by Players

3.3.8 Hemoglobin Meter Market Size by Players

3.3.9 Other Market Size by Players

3.4 Global POCT Diagnostic Analyzer Market Concentration and Dynamics

3.4.1 Global Market Concentration (CR5 and HHI)

3.4.2 Entrant/Exit Impact Analysis

3.4.3 Strategic Moves: M&A, Expansion, R&D Investment

muLu

4 Global Product Segmentation Analysis

4.1 Global POCT Diagnostic Analyzer Revenue Trends by Type

4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.1.2 Global Revenue Market Share by Type (2020-2031)

4.2 Key Product Attributes and Differentiation

4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.3.1 High-Growth Niches and Adoption Drivers

4.3.2 Profitability Hotspots and Cost Drivers

4.3.3 Substitution Threats

muLu

5 Global Downstream Application Analysis

5.1 Global POCT Diagnostic Analyzer Revenue by Application

5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.1.2 Revenue Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Downstream Customer Analysis

5.2.1 Top Customers by Region

5.2.2 Top Customers by Application

muLu

6 North America

6.1 North America Market Size (2020-2031)

6.2 North America Key Players Revenue in 2024

6.3 North America POCT Diagnostic Analyzer Market Size by Type (2020-2031)

6.4 North America POCT Diagnostic Analyzer Market Size by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America POCT Diagnostic Analyzer Market Size by Country

6.6.1 North America Revenue Trends by Country

6.6.2 US

6.6.3 Canada

6.6.4 Mexico

muLu

7 Europe

7.1 Europe Market Size (2020-2031)

7.2 Europe Key Players Revenue in 2024

7.3 Europe POCT Diagnostic Analyzer Market Size by Type (2020-2031)

7.4 Europe POCT Diagnostic Analyzer Market Size by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe POCT Diagnostic Analyzer Market Size by Country

7.6.1 Europe Revenue Trends by Country

7.6.2 Germany

7.6.3 France

7.6.4 U.K.

7.6.5 Italy

7.6.6 Russia

muLu

8 Asia-Pacific

8.1 Asia-Pacific Market Size (2020-2031)

8.2 Asia-Pacific Key Players Revenue in 2024

8.3 Asia-Pacific POCT Diagnostic Analyzer Market Size by Type (2020-2031)

8.4 Asia-Pacific POCT Diagnostic Analyzer Market Size by Application (2020-2031)

8.5 Asia-Pacific Growth Accelerators and Market Barriers

8.6 Asia-Pacific POCT Diagnostic Analyzer Market Size by Region

8.6.1 Asia-Pacific Revenue Trends by Region

8.7 China

8.8 Japan

8.9 South Korea

8.10 Australia

8.11 India

8.12 Southeast Asia

8.12.1 Indonesia

8.12.2 Vietnam

8.12.3 Malaysia

8.12.4 Philippines

8.12.5 Singapore

muLu

9 Central and South America

9.1 Central and South America Market Size (2020-2031)

9.2 Central and South America Key Players Revenue in 2024

9.3 Central and South America POCT Diagnostic Analyzer Market Size by Type (2020-2031)

9.4 Central and South America POCT Diagnostic Analyzer Market Size by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America POCT Diagnostic Analyzer Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

muLu

10 Middle East and Africa

10.1 Middle East and Africa Market Size (2020-2031)

10.2 Middle East and Africa Key Players Revenue in 2024

10.3 Middle East and Africa POCT Diagnostic Analyzer Market Size by Type (2020-2031)

10.4 Middle East and Africa POCT Diagnostic Analyzer Market Size by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa POCT Diagnostic Analyzer Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Israel

10.6.4 Egypt

10.6.5 South Africa

muLu

11 Corporate Profile

11.1 Getein Biotech

11.1.1 Getein Biotech Corporation Information

11.1.2 Getein Biotech Business Overview

11.1.3 Getein Biotech POCT Diagnostic Analyzer Product Features and Attributes

11.1.4 Getein Biotech POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)

11.1.5 Getein Biotech POCT Diagnostic Analyzer Revenue by Product in 2024

11.1.6 Getein Biotech POCT Diagnostic Analyzer Revenue by Application in 2024

11.1.7 Getein Biotech POCT Diagnostic Analyzer Revenue by Geographic Area in 2024

11.1.8 Getein Biotech POCT Diagnostic Analyzer SWOT Analysis

11.1.9 Getein Biotech Recent Developments

11.2 Guangzhou Wondfo Biotech

11.2.1 Guangzhou Wondfo Biotech Corporation Information

11.2.2 Guangzhou Wondfo Biotech Business Overview

11.2.3 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer Product Features and Attributes

11.2.4 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)

11.2.5 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer Revenue by Product in 2024

11.2.6 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer Revenue by Application in 2024

11.2.7 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer Revenue by Geographic Area in 2024

11.2.8 Guangzhou Wondfo Biotech POCT Diagnostic Analyzer SWOT Analysis

11.2.9 Guangzhou Wondfo Biotech Recent Developments

11.3 EasyDiagnosis Biomedicine

11.3.1 EasyDiagnosis Biomedicine Corporation Information

11.3.2 EasyDiagnosis Biomedicine Business Overview

11.3.3 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer Product Features and Attributes

11.3.4 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)

11.3.5 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer Revenue by Product in 2024

11.3.6 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer Revenue by Application in 2024

11.3.7 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer Revenue by Geographic Area in 2024

11.3.8 EasyDiagnosis Biomedicine POCT Diagnostic Analyzer SWOT Analysis

11.3.9 EasyDiagnosis Biomedicine Recent Developments

11.4 Roche Holding AG

11.4.1 Roche Holding AG Corporation Information

11.4.2 Roche Holding AG Business Overview

11.4.3 Roche Holding AG POCT Diagnostic Analyzer Product Features and Attributes

11.4.4 Roche Holding AG POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)

11.4.5 Roche Holding AG POCT Diagnostic Analyzer Revenue by Product in 2024

11.4.6 Roche Holding AG POCT Diagnostic Analyzer Revenue by Application in 2024

11.4.7 Roche Holding AG POCT Diagnostic Analyzer Revenue by Geographic Area in 2024

11.4.8 Roche Holding AG POCT Diagnostic Analyzer SWOT Analysis

11.4.9 Roche Holding AG Recent Developments

11.5 ABBOTT

11.5.1 ABBOTT Corporation Information

11.5.2 ABBOTT Business Overview

11.5.3 ABBOTT POCT Diagnostic Analyzer Product Features and Attributes

11.5.4 ABBOTT POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)

11.5.5 ABBOTT POCT Diagnostic Analyzer Revenue by Product in 2024

11.5.6 ABBOTT POCT Diagnostic Analyzer Revenue by Application in 2024

11.5.7 ABBOTT POCT Diagnostic Analyzer Revenue by Geographic Area in 2024

11.5.8 ABBOTT POCT Diagnostic Analyzer SWOT Analysis

11.5.9 ABBOTT Recent Developments

11.6 Siemens Healthcare

11.6.1 Siemens Healthcare Corporation Information

11.6.2 Siemens Healthcare Business Overview

11.6.3 Siemens Healthcare POCT Diagnostic Analyzer Product Features and Attributes

11.6.4 Siemens Healthcare POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)

11.6.5 Siemens Healthcare Recent Developments

11.7 BD

11.7.1 BD Corporation Information

11.7.2 BD Business Overview

11.7.3 BD POCT Diagnostic Analyzer Product Features and Attributes

11.7.4 BD POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)

11.7.5 BD Recent Developments

11.8 Quidel

11.8.1 Quidel Corporation Information

11.8.2 Quidel Business Overview

11.8.3 Quidel POCT Diagnostic Analyzer Product Features and Attributes

11.8.4 Quidel POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)

11.8.5 Quidel Recent Developments

11.9 Danaher Corp

11.9.1 Danaher Corp Corporation Information

11.9.2 Danaher Corp Business Overview

11.9.3 Danaher Corp POCT Diagnostic Analyzer Product Features and Attributes

11.9.4 Danaher Corp POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)

11.9.5 Danaher Corp Recent Developments

11.10 Abaxis

11.10.1 Abaxis Corporation Information

11.10.2 Abaxis Business Overview

11.10.3 Abaxis POCT Diagnostic Analyzer Product Features and Attributes

11.10.4 Abaxis POCT Diagnostic Analyzer Revenue and Gross Margin (2020-2025)

11.10.5 Company Ten Recent Developments

muLu

12 POCT Diagnostic AnalyzerIndustry Chain Analysis

12.1 POCT Diagnostic Analyzer Industry Chain

12.2 Upstream Analysis

12.2.1 Upstream Key Suppliers

12.3 Middlestream Analysis

12.4 Downstream Sales Model and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

muLu

13 POCT Diagnostic Analyzer Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

muLu

14 Key Findings in the Global POCT Diagnostic Analyzer Study

muLu

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

den_biaoTiZhungShi

TABLE OF FIGURES

muLu

List of Tables

Table 1. Global POCT Diagnostic Analyzer Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global POCT Diagnostic Analyzer Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global POCT Diagnostic Analyzer Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global POCT Diagnostic Analyzer Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global POCT Diagnostic Analyzer Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global POCT Diagnostic Analyzer Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global POCT Diagnostic Analyzer Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global POCT Diagnostic Analyzer by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POCT Diagnostic Analyzer as of 2024)
Table 11. Global POCT Diagnostic Analyzer Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global POCT Diagnostic Analyzer Companies Headquarters
Table 13. Global POCT Diagnostic Analyzer Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global POCT Diagnostic Analyzer Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global POCT Diagnostic Analyzer Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global POCT Diagnostic Analyzer Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global POCT Diagnostic Analyzer Revenue by Application (2026-2031) & (US$ Million)
Table 21. POCT Diagnostic Analyzer High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America POCT Diagnostic Analyzer Growth Accelerators and Market Barriers
Table 25. North America POCT Diagnostic Analyzer Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe POCT Diagnostic Analyzer Growth Accelerators and Market Barriers
Table 27. Europe POCT Diagnostic Analyzer Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific POCT Diagnostic Analyzer Growth Accelerators and Market Barriers
Table 29. Asia-Pacific POCT Diagnostic Analyzer Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America POCT Diagnostic Analyzer Investment Opportunities and Key Challenges
Table 31. Central and South America POCT Diagnostic Analyzer Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa POCT Diagnostic Analyzer Investment Opportunities and Key Challenges
Table 33. Middle East and Africa POCT Diagnostic Analyzer Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Getein Biotech Corporation Information
Table 35. Getein Biotech Description and Major Businesses
Table 36. Getein Biotech Product Features and Attributes
Table 37. Getein Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Getein Biotech Revenue Proportion by Product in 2024
Table 39. Getein Biotech Revenue Proportion by Application in 2024
Table 40. Getein Biotech Revenue Proportion by Geographic Area in 2024
Table 41. Getein Biotech POCT Diagnostic Analyzer SWOT Analysis
Table 42. Getein Biotech Recent Developments
Table 43. Guangzhou Wondfo Biotech Corporation Information
Table 44. Guangzhou Wondfo Biotech Description and Major Businesses
Table 45. Guangzhou Wondfo Biotech Product Features and Attributes
Table 46. Guangzhou Wondfo Biotech Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Guangzhou Wondfo Biotech Revenue Proportion by Product in 2024
Table 48. Guangzhou Wondfo Biotech Revenue Proportion by Application in 2024
Table 49. Guangzhou Wondfo Biotech Revenue Proportion by Geographic Area in 2024
Table 50. Guangzhou Wondfo Biotech POCT Diagnostic Analyzer SWOT Analysis
Table 51. Guangzhou Wondfo Biotech Recent Developments
Table 52. EasyDiagnosis Biomedicine Corporation Information
Table 53. EasyDiagnosis Biomedicine Description and Major Businesses
Table 54. EasyDiagnosis Biomedicine Product Features and Attributes
Table 55. EasyDiagnosis Biomedicine Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. EasyDiagnosis Biomedicine Revenue Proportion by Product in 2024
Table 57. EasyDiagnosis Biomedicine Revenue Proportion by Application in 2024
Table 58. EasyDiagnosis Biomedicine Revenue Proportion by Geographic Area in 2024
Table 59. EasyDiagnosis Biomedicine POCT Diagnostic Analyzer SWOT Analysis
Table 60. EasyDiagnosis Biomedicine Recent Developments
Table 61. Roche Holding AG Corporation Information
Table 62. Roche Holding AG Description and Major Businesses
Table 63. Roche Holding AG Product Features and Attributes
Table 64. Roche Holding AG Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Roche Holding AG Revenue Proportion by Product in 2024
Table 66. Roche Holding AG Revenue Proportion by Application in 2024
Table 67. Roche Holding AG Revenue Proportion by Geographic Area in 2024
Table 68. Roche Holding AG POCT Diagnostic Analyzer SWOT Analysis
Table 69. Roche Holding AG Recent Developments
Table 70. ABBOTT Corporation Information
Table 71. ABBOTT Description and Major Businesses
Table 72. ABBOTT Product Features and Attributes
Table 73. ABBOTT Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. ABBOTT Revenue Proportion by Product in 2024
Table 75. ABBOTT Revenue Proportion by Application in 2024
Table 76. ABBOTT Revenue Proportion by Geographic Area in 2024
Table 77. ABBOTT POCT Diagnostic Analyzer SWOT Analysis
Table 78. ABBOTT Recent Developments
Table 79. Siemens Healthcare Corporation Information
Table 80. Siemens Healthcare Description and Major Businesses
Table 81. Siemens Healthcare Product Features and Attributes
Table 82. Siemens Healthcare Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Siemens Healthcare Recent Developments
Table 84. BD Corporation Information
Table 85. BD Description and Major Businesses
Table 86. BD Product Features and Attributes
Table 87. BD Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. BD Recent Developments
Table 89. Quidel Corporation Information
Table 90. Quidel Description and Major Businesses
Table 91. Quidel Product Features and Attributes
Table 92. Quidel Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Quidel Recent Developments
Table 94. Danaher Corp Corporation Information
Table 95. Danaher Corp Description and Major Businesses
Table 96. Danaher Corp Product Features and Attributes
Table 97. Danaher Corp Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Danaher Corp Recent Developments
Table 99. Abaxis Corporation Information
Table 100. Abaxis Description and Major Businesses
Table 101. Abaxis Product Features and Attributes
Table 102. Abaxis Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Abaxis Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
muLu

List of Figures

Figure 1. POCT Diagnostic Analyzer Product Picture
Figure 2. Global POCT Diagnostic Analyzer Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Urinalysis Analyzers Product Picture
Figure 4. Blood Glucose Meter Product Picture
Figure 5. Clinical Chemistry Analyzers Product Picture
Figure 6. Blood Gas Analyzers Product Picture
Figure 7. INR Test Meter Product Picture
Figure 8. Cardiac Marker Analyzers Product Picture
Figure 9. Electrolyte Analyzers Product Picture
Figure 10. Hemoglobin Meter Product Picture
Figure 11. Other Product Picture
Figure 12. Global POCT Diagnostic Analyzer Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Hospital
Figure 14. Clinic
Figure 15. Laboratory
Figure 16. Others
Figure 17. POCT Diagnostic Analyzer Report Years Considered
Figure 18. Global POCT Diagnostic Analyzer Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 20. Global POCT Diagnostic Analyzer Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 21. Global POCT Diagnostic Analyzer Revenue Market Share by Region (2020-2031)
Figure 22. Global POCT Diagnostic Analyzer Revenue Market Share Ranking (2024)
Figure 23. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 24. Urinalysis Analyzers Revenue Market Share by Player in 2024
Figure 25. Blood Glucose Meter Revenue Market Share by Player in 2024
Figure 26. Clinical Chemistry Analyzers Revenue Market Share by Player in 2024
Figure 27. Blood Gas Analyzers Revenue Market Share by Player in 2024
Figure 28. INR Test Meter Revenue Market Share by Player in 2024
Figure 29. Cardiac Marker Analyzers Revenue Market Share by Player in 2024
Figure 30. Electrolyte Analyzers Revenue Market Share by Player in 2024
Figure 31. Hemoglobin Meter Revenue Market Share by Player in 2024
Figure 32. Other Revenue Market Share by Player in 2024
Figure 33. Global POCT Diagnostic Analyzer Revenue Market Share by Type (2020-2031)
Figure 34. Global POCT Diagnostic Analyzer Revenue Market Share by Application (2020-2031)
Figure 35. North America POCT Diagnostic Analyzer Revenue YoY (2020-2031) & (US$ Million)
Figure 36. North America Top 5 Players POCT Diagnostic Analyzer Revenue (US$ Million) in 2024
Figure 37. North America POCT Diagnostic Analyzer Revenue (US$ Million) by Type (2020 - 2031)
Figure 38. North America POCT Diagnostic Analyzer Revenue (US$ Million) by Application (2020-2031)
Figure 39. US POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 40. Canada POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 41. Mexico POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 42. Europe POCT Diagnostic Analyzer Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Players POCT Diagnostic Analyzer Revenue (US$ Million) in 2024
Figure 44. Europe POCT Diagnostic Analyzer Revenue (US$ Million) by Type (2020-2031)
Figure 45. Europe POCT Diagnostic Analyzer Revenue (US$ Million) by Application (2020-2031)
Figure 46. Germany POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 47. France POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 48. U.K. POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 49. Italy POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 50. Russia POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 51. Asia-Pacific POCT Diagnostic Analyzer Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Players POCT Diagnostic Analyzer Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific POCT Diagnostic Analyzer Revenue (US$ Million) by Type (2020-2031)
Figure 54. Asia-Pacific POCT Diagnostic Analyzer Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 56. Japan POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 58. Australia POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 59. India POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 60. Indonesia POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 61. Vietnam POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 62. Malaysia POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 63. Philippines POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 64. Singapore POCT Diagnostic Analyzer Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America POCT Diagnostic Analyzer Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Players POCT Diagnostic Analyzer Revenue (US$ Million) in 2024
Figure 67. Central and South America POCT Diagnostic Analyzer Revenue (US$ Million) by Type (2020-2031)
Figure 68. Central and South America POCT Diagnostic Analyzer Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil POCT Diagnostic Analyzer Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina POCT Diagnostic Analyzer Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East and Africa POCT Diagnostic Analyzer Revenue YoY (2020-2031) & (US$ Million)
Figure 72. Middle East and Africa Top 5 Players POCT Diagnostic Analyzer Revenue (US$ Million) in 2024
Figure 73. South America POCT Diagnostic Analyzer Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa POCT Diagnostic Analyzer Revenue (US$ Million) by Application (2020-2031)
Figure 75. GCC Countries POCT Diagnostic Analyzer Revenue (2020-2025) & (US$ Million)
Figure 76. Israel POCT Diagnostic Analyzer Revenue (2020-2025) & (US$ Million)
Figure 77. Egypt POCT Diagnostic Analyzer Revenue (2020-2025) & (US$ Million)
Figure 78. South Africa POCT Diagnostic Analyzer Revenue (2020-2025) & (US$ Million)
Figure 79. POCT Diagnostic Analyzer Industry Chain Mapping
Figure 80. Channels of Distribution (Direct Vs Distribution)
Figure 81. Bottom-up and Top-down Approaches for This Report
Figure 82. Data Triangulation
Figure 83. Key Executives Interviewed
den_biaoTiZhungShi

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global POCT Diagnostic Analyzer market size from 2025 to 2031?zhanKai
The annual compound growth rate of the global POCT Diagnostic Analyzer market is 4.2% 2025 to 2031.
What was the global market size of POCT Diagnostic Analyzer in 2031?shouQi
Which companies rank high in the global POCT Diagnostic Analyzer market?shouQi
Which region is expected to have the highest market share?shouQi
What was the global market size of POCT Diagnostic Analyzer in 2025?shouQi
den_biaoTiZhungShi

Related Reports

Global POCT Diagnostic Analyzer Market Outlook, In‑Depth Analysis & Forecast to 2031

Industry: Medical Devices & Consumables

Published Date: 2025-11-02

Pages: 129 Pages

Report ld: 5344942

CHOOSE LICENSE TYPE
tip

USD 4900.00

tip

USD 7350.00

tip

USD 9800.00

Add to Cart

Add to Cart

Buy Now

Buy Now

HAVE A QUESTION?
SIMON LEE

English,Chinese

Offline

HITESH

English, Hindi

Offline

TANG XIN

Japanese,English

Online

SUNG-BIN YOON

SUNG-BIN YOON

+82-2883 1278

Korean, English

Online

YUJIE TIAN

Chinese, English

Online

DAMON

Chinese, English

Online

General Email:

REPORT COVERAGE

den_ic8

DESCRIPTION

zhankai
den_ic7

OVERVIEW

den_ic7

MARKET SEGMENTATION

den_ic7

CHAPTER OUTLINE

den_ic7

WHY THIS REPORT

den_ic7

QYRESEARCH'S STRENGTHS

den_ic8

TABLE OF CONTENTS

den_ic8

TABLE OF FIGURES

den_ic8

RLEATED REPORTS

INTEREST IN THIS REPORT?

yangBenGet A Free Sample

baoJia Request For Quotation

OR

NEED A CUSTOMIZED REPORT?

DingZhiCustomized Report

biaoTi

WORLD WIDE OFFICE

application for samples

Request Sample

Custom reports

Pre-Order Enquiry

Add to Cart

Add to Cart

Buy Now

Buy Now